Congratulations to Dr. Rachel Weber and Dr. Ellen McGlinchey, former Neuroscience Ph.D. students, for being selected as co-recipients of the Annual Distinguished Graduate Award of the College of Graduate Studies. Rachel is a postdoc here at MUSC — her research is studying the mechanism underlying oxytocin’s effect on drug seeking (Reichel lab). Ellen is the Study/Director/Research Scientist at Charles River Laboratories in the Greater Philadelphia area.
More information on Drs. Weber and McGlinchey can be found on page 4 in the May 19, 2017 issue of The Catalyst.
The Neuroscience Institute (NI) of MUSC is a center of neuroscience research, education, and treatment that facilitates interdisciplinary collaboration among basic and clinical neuroscientists. It is not housed in a single department, but rather is a university-wide institute with the aim of supporting neuroscience research in any department or college of MUSC. The primary focus of the NI is to promote translational research to bridge the gap between the basic sciences and clinical sciences. It brings together the minds necessary to treat and cure neurodegenerative, neuropsychiatric, addiction, and sleep disorders and provides many of the resources needed to achieve these goals. Today, scientists at the NI focus on cognitive neuroscience, neurodegenerative disease, addiction, pain, mood, and sleep disorders research, to name a few areas. The Neuroscience Institute also emphasizes development, education, and outreach.
Jacqueline F. McGinty, Ph.D.
Director of the Neuroscience Institute at MUSC